Turning Science into Care: The Fierce 50 of 2026
TL;DR Summary
Fierce 50 of 2026 honors a diverse group of leaders and organizations in healthcare, pharma and biotech who close the gap between cutting-edge science and real-world patient access, recognizing efforts from cancer and rare diseases to public health outreach and reducing medical debt.
- Fierce 50 of 2026 fiercepharma.com
- Amy Green, Ph.D., Recognized as a 2026 Fierce 50 Health Equity Honoree PR Newswire
- GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree Business Wire
- Dr. Roxana Daneshjou Recognized as a 2026 Fierce 50 Honoree Yahoo Finance
- Hopelab’s Amy Green Named 2026 Fierce 50 Health Equity Honoree citybiz
Reading Insights
Total Reads
1
Unique Readers
3
Time Saved
2 min
vs 3 min read
Condensed
90%
411 → 43 words
Want the full story? Read the original article
Read on fiercepharma.com